The Triple Marker Test is a prenatal screening test performed during the second trimester to assess the risk of certain chromosomal abnormalities and birth defects in the developing baby.
The Triple Marker Test is a maternal blood screening test carried out during the second trimester of pregnancy, typically between 15 to 20 weeks. It measures the levels of three important substances in the mother’s blood:
These markers help evaluate the risk of chromosomal abnormalities and neural tube defects in the fetus. It is a non-invasive screening test and does not pose any risk to the mother or baby.
The purpose of this test is to: